HIV prevalence and MDR TB among DOTS attendees in a rural area of Haryana, India  by kumar, R. et al.
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ffectively TB control program would work. The present
tudy attempted to describe the transmission of drug resis-
ant TB in two comparable rural Chinese areas albeit with
ifferent duration of direct observed treatment, short-
ourse(DOTS) implementation, as well as to discuss about
ts possible implication for TB control policies.
Methods: Setting in two rural counties: ten years’ DOTS
overed Deqing and one year’s DOTS covered Guanyun, this
tudy included the pulmonary drug resistant TB patients
egistered in local TB dispensaries as the subject. Propor-
ion method and DNA sequencing determined drug resistant
attern and genetic mutation of M.TB isolates. IS6110-RFLP
dentiﬁed clustered patients and their epidemiological link
as conﬁrmed using concentric circle method.
Results: Totally 223 of 351 isolates(63.5%) were resis-
ant to at least one anti-TB drug, including 53(15.1%)
imultaneously resistant to isoniazid and rifampicin or
ultidrug resistant(MDR-TB,18 from Deqing and 35 from
uanyun). Of the 168 patterns identiﬁed by IS6110-RFLP,
0 were shared only between drug resistant isolates; 12
ere shared between the drug resistant isolates and the
an-drug sensitive isolates. Deqing and Guanyun had sig-
iﬁcantly different cluster proportion of drug resistant
B(32/101.vs.55/122,p = 0.041) but similar cluster pro-
ortion of MDR-TB isolates(11/19.vs.22/34,p = 0.624). The
igniﬁcant high cluster proportion was observed in the previ-
us treated patients both in two counties but in the sputum
mear positive patients with cavitaries alone in Guanyun,
o does happen to those infected with the strain from Bei-
ing genotype and resistant to isonazid and/or rifampicin.
f 87 clustered drug resistant strain, 67.8% was clustered
n same or neighboring village!The remained 71.4% were
catted along the trafﬁc arteries.
Conclusion: Transmission pattern of drug resistant TB
as consistent with attenuated properties of pathogen as
ell as social activity of rural populations. Meanwhile, DOTS
tself might not work enough on the recent transmission of
DR-TB. These observations might suggest the need of sup-
lementing the additional strategies, including active case
nding within village and effective treatment on patients
reviously treated or with cavitaries.
oi:10.1016/j.ijid.2010.02.1810
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valuation of cost and methods for detecting latent
uberculosis infection among target individual groups in
rinidad & Tobago
.E. Akpaka1,∗, S. Baboolal 2, D. Ramoutar3
The University of the West Indies, Faculty of Medical Sci-
nces, Champ Fleurs, Trinidad and Tobago
The University of the West Indies, Faculty of Medical Sci-
nces, St. Augustine, Trinidad and Tobago
North Regional Health Authority, Caura, Trinidad and
obago
Background: A huge amount of valuable time and
esources is expended in the country using tuberculin skin
est (TST) assay to screen for TB contacts and other subjects
n the country. This study was carried out to compare using
ST and QuantiFERON®-TB gold (QFT-G) assays in screen-
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ng and diagnosis of latent tuberculosis infection (LTBI) in a
ross section of high risk individuals for LTBI in Trinidad and
obago.
Methods: During a 9-months period, over 550 subjects
ncluding contacts of TB patients (n = 200), HIV positive
atients (n = 70), health care workers (45), prison inmates
65) and TB patients (180) used as controls were recruited
or the study. Blood specimen was drawn from the subjects
nd processed in the laboratory using QuantiFERON®-TB
old (QFT-G) kit and tuberculin solution was administered
n the forearm. Data were analyzed with Epi Info 3.5.1 soft-
are (CDC, Atlanta, GA, USA). The chi-squared test and
isher’s exact test were used as appropriate to compare
ata from the different groups. Data were descriptive and
ere reported as comparisons of frequency distributions. A
value < 0.05 was considered signiﬁcant.
Results: The QFT-G assay detected LTBI in 41.1% of the
ubjects with the highest (65.6%) positive results occurring
mong control group. The TST test detected LTBI in 19.9%
f the subjects, a lower result than the QFT-G method,
p = 0.001) Overall, QFT-G method detected more LTBI in
ll the different groups than the TST except among prison
nmates where the detection was almost similar. The QFT-
gave a high rate of indeterminate and non reactive
esults among HIV positive subjects. Despite using less time
ompleting QFT-G assay (23.3 hours) against TST method
70.2 hours, p < 0.0001), the cost was less performing the
ST in each subject ($3.70) when compared to QFT-G that
as $18.60, and the difference was statistically signiﬁcant,
= 0.0008.
Conclusion: The QFT-G gave a faster turn around time
esult, effective and more expensive than TST method.
owever, because the QFT-G gave indeterminate and non
eactive response for immunocompromised subjects such as
IV positive patients, care must be taken when screening
r making a diagnosis of LTBI based on QFT-G results in a
oor resource and high HIV prevalence setting like Trinidad
Tobago.
oi:10.1016/j.ijid.2010.02.1811
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IV prevalence and MDR TB among DOTS attendees in a
ural area of Haryana, India
. kumar ∗, S. Rai, S. Kant, K. Anand, L. Dar, U. Singh
All India Institute of Medical Sciences, New Delhi, Delhi,
ndia
Background: MDR-TB was a potential threat to tubercu-
osis control in India. We wanted to estimate the prevalence
f HIV infection and MDR TB among DOTS attendees in Bal-
abgarh, Haryana, India.
Methods: The study was carried out in two DOTS cen-
res of Ballabgarh Tehsil of district Faridabad, Haryana. It
as a health facility based cross sectional survey. Study sub-
ects were all TB patients (Pulmonary and Extra Pulmonary)
ho were registered for DOTS. Data was collected from Jan-
ary 2007 to June 2008. We enrolled 413 eligible patients
ho were informed about the study objectives and written
onsent was obtained. All patients were offered free Liver
unction Test. Unlinked anonymous testing on aliquot of LFT
trac
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attention on TB diagnosis with commitment and training of
professionals on DOTS Strategy. They don’t perceive DOT as a
barrier, but as a strengthening for a very difﬁcult treatment.
doi:10.1016/j.ijid.2010.02.181314th International Congress on Infectious Diseases (ICID) Abs
blood samples was performed after removing all identiﬁers.
HIV testing was done using three E/R/S. Sputum was col-
lected from patients belonging to Categories I and II, under
Revised National TB Programme. Anti TB sensitivity testing
was done on randomly selected patients of Category I (50%
of patients) and all of the Category II patients.
Results: Four hundred and thirteen TB patients [CAT
I-220(53.3%), II-101(24.5%), and III-92 (22.2%)] were inter-
viewed and blood samples could be obtained from 368
patients (89.1%). Four blood samples got contaminated and
labels of ten samples was lost during the transportation.
Finally, of the 354 samples tested two were found HIV sero
reactive. Prevalence of HIV among TB patients was 0.56%
(95% CI 0.068-2.02). Sputum collection was attempted from
211 patients. Thirty eight patients (18%) had difﬁculty in
producing sputum. Of the 173 sputum samples collected,
eighty were culture positive for Mycobacterium tuberculo-
sis. Among them nine samples were found to be multi drug
resistant by RLBA. The prevalence of MDR among TB patients
was 11.25% (95% CI 5.27 — 20.28).
Conclusion: HIV prevalence was low and similar to the
rate observed among pregnant women (0.13%) who could
be considered as proxy to general low risk population. Multi
drug resistance was high among TB patients. It was reassur-
ing that HIV — TB co infection was low and none of the MDR
TB patients were HIV positive.
doi:10.1016/j.ijid.2010.02.1812
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The social representation of DOT-related tuberculosis by
patients of Guarulhos at the metropolitan area of Sao
Paulo, Brazil
V. Souza Pinto ∗, V.M.N. Galesi, M.I.P.S. Braz
Sao Paulo State Secretary of Health, Sao Paulo, SP, Brazil
Background: Setting: Public healthcare service (HCS)
of Guarulhos municipality, in the metropolitan area of
Sao Paulo, Brazil. Objective: Analyzing the individual per-
ception of patients concerned to supervised treatment
(DOT)-related tuberculosis (TB) offered by HCS.
Methods: Qualitative approach using interviews with
patients. The Collective Discourse (CD) allows capturing a
pool of social representations, gathering answers from dif-
ferent individuals with discourse content of similar sense to
build collective statements.
Results: Answers of 65 patients (interviewers can give
more than one central idea), in three questions (Q) about
DOT — (Q1) ‘Someone tells you about DOT. What is DOT
for you?’; (Q2) ‘Tell us about DOT on a daily basis?’; and
(Q3) ‘DOT takes six months and after one month patients
do not have more symptoms. Why do you think this hap-
pen?’. According to Table 1 the central ideas presented
were: Q1, (A) It’s a guidance regarding where treatment
will take place; (B) B. It’s a guidance regarding time and fre-
quency of TB drugs; and (C) It’s an explanation about TB. Q2,
(A) Patients report to go to HCS to take TB drugs; (B) Patients
report the side-effects to TB drugs and to the aggressive
treatment; (C) Patients report that treatment is incorpo-
rated on routine and do not affect the routine; and (D)
Patients report improvement of health condition after thets e149
eginning of treatment. Q3, (A) Because symptoms decrease
r disappear and patients feel good and think they’re cured;
B) Due to lack of consciousness and responsibility and lack
f love to life, health and to the next one; (C) Due to side
ffects and lack of information regarding the treatment of
B.
Table 1 The social representation of DOT-related tuber-
ulosis by patients of Guarulhos at the metropolitan area of
ao Paulo, Brazil
uestions Results
Central Ideas presented** N N1 N2 %
‘Someone tells
you about DOT.
What is DOT for
you?’
A. it’s a guidance
regarding where
treatment will take place
65 119 45 69.2
B. It’s a guidance
regarding time and
frequency of TB drugs
30 46.2
C. It’s an explanation
about TB
17 26.2
D. Others (7 categories) 27 -
‘Tell us about
DOT on a daily
basis?’
A. Patients report to go to
HCS to take TB drugs
82 24 36.9
B. Patients report the
side-effects to TB drugs
and to the aggressive
treatment
17 26.2
C. Patients report that
treatment is incorporated
on routine and do not
affect the routine
14 21.5
D. Patients report
improvement of health
condition after the
beginning of treatment
12 18.5
E. Others (5 categories) 15 -
‘DOT takes six
months and
after one month
patients do not
have more
symptoms. Why
do you think this
happen?’
A. Because symptoms
decrease or disappear and
patients feel good and
think they’re cured
90 39 60.0
B. Due to lack of
consciousness and
responsibility and lack of
love to life, health and to
the next one
17 26.2
C. Due to side effects and
lack of information
regarding the treatment
of TB
14 21.5
D. Others (8 categories) 20 -
** Interviewers can give more than one central idea
N Number of TB patients interviewed in the study
N1 Number of answers presented in this question
N2 Number of ideas in the category presented (unfolding
f central ideas)
Conclusion: TB patients have correct knowledge about
he disease, understanding the necessity of DOT and also
hey report their ways on the process of TB diagnosis which
an their treatments. So, it is necessary that HCS pay
